Health insurer Elevance Health Inc. (NYSE:ELV) is scheduled to release its second quarter 2025 financial results on July 17.
Analysts estimate adjusted earnings of $9.197 per share on sales of $48.24 billion, as per data from Benzinga Pro.
UnitedHealth Group Inc. (NYSE:UNH) has been the first major health insurer to report quarterly earnings for several quarters. However, this quarter, the insurance giant will release its second quarter 2025 financial results on July 29.
As it’s the biggest player in the industry, Forbes writes that analysts and investors often use its results to gauge the sector’s overall health.
Also Read: UnitedHealth, Centene Hit Hard By Guidance Shock, Trump’s Medicaid Push
All eyes will be on the sector after Centene Corp’s (NYSE:CNC) withdrawal of its 2025 GAAP and adjusted diluted EPS guidance, which stems from its initial review of 2025 industry data from Wakely, an independent actuarial firm.
While withdrawing its comprehensive EPS guidance, Centene has reaffirmed its fiscal year 2025 adjusted EPS to be greater than $7.25, aligning with the consensus of $7.23.
UnitedHealth suspended its 2025 outlook in May, citing that care activity continued to accelerate.
Earlier in July, managed healthcare service provider under the Medicaid and Medicare programs, Molina Healthcare, Inc. (NYSE:MOH), issued preliminary second-quarter results and lowered its full-year 2025 earnings outlook, citing rising medical costs across its Medicaid, Medicare, and state marketplace businesses.
The company expects Q2 adjusted earnings of approximately $5.50 per share—slightly below earlier forecasts—due to expected cost pressures that will persist into the second half of the year.
As a result, Molina cut its full-year 2025 adjusted EPS guidance to $21.50 -$22.50, down from at least $24.50 previously. The new forecast reflects a consolidated pre-tax margin just under 4%, at the low end of the company’s long-term target.
Forbes adds Centene’s announcement is just the latest in a series of updates from health insurers who, over the past two years, have had a hard time managing the costs of people enrolled in government-subsidized health plans.
Price Action: UNH stock is down 1.29% at $300.19 at the last check on Monday.
Read Next:
Image: Shutterstock
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。